Search
Close this search box.

Regulatory Factsheet

Orphan Drug Designation (EU & UK)

In order to be eligible for Orphan Drug Designation (ODD) with the EMA, a product must fulfill certain criteria for designation as an orphan medicine so that it can benefit from incentives such as protection from competition once on the market. Download our 2 page Orphan Drug Designation (EU & UK) factsheet for more information.

For more information on how the Boyds team can support your drug development project, get in touch.
Facebook
Twitter
LinkedIn